MARSHALL WACE, LLP

Holdings History for Black Diamond Therapeutics, Inc. - Common Stock, par value $0.0001 per share (BDTX)

Symbol: BDTX on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	-0%	$2,697,515	1,110,088	-189,120	-15%	$2.43	Q4 2025
30 Sep 2025	0.01%	+0%	$4,923,996	1,299,208	+561,333	+76%	$3.79	Q3 2025
30 Jun 2025	0%	+0%	$1,829,929	737,875	+737,875	NEW	$2.48	Q2 2025
31 Dec 2024		-0%	$0	0	-97,166	-100%	$2.39	Q4 2024
30 Sep 2024	0%	+0%	$422,672	97,166	+2,629	+2.8%	$4.35	Q3 2024
30 Jun 2024	0%	+0%	$440,543	94,537	+94,537	NEW	$4.66	Q2 2024
31 Mar 2024		-0%	$0	0	-22,924	-100%	$2.39	Q1 2024
31 Dec 2023	0%	+0%	$64,417	22,924	+22,924	NEW	$2.81	Q4 2023
30 Jun 2021		-0.02%	$0	0	-140,232	-100%	$2.39	Q2 2021
31 Mar 2021	0.02%	+0.01%	$3,402,000	140,232	+97,151	+226%	$24.26	Q1 2021
31 Dec 2020	0.01%	+0.01%	$1,381,000	43,081	+43,081	NEW	$32.06	Q4 2020
30 Sep 2020		-0%	$0	0	-8,007	-100%	$2.39	Q3 2020
30 Jun 2020	0%	-0.01%	$338,000	8,007	-20,783	-72%	$42.21	Q2 2020
31 Mar 2020	0.01%	+0.01%	$718,000	28,790	+28,790	NEW	$24.94	Q1 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.